|
|
|
|
| LEADER |
01346nmm a2200277 u 4500 |
| 001 |
EB001868243 |
| 003 |
EBX01000000000000001031670 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
190710 ||| eng |
| 020 |
|
|
|a 9780199968749
|
| 050 |
|
4 |
|a HD9665.5
|
| 100 |
1 |
|
|a Danzon, Patricia Munch
|
| 245 |
0 |
0 |
|a The Oxford handbook of the economics of the biopharmaceutical industry
|h Elektronische Ressource
|c edited by Patricia M. Danzon and Sean Nicholson
|
| 246 |
3 |
1 |
|a Economics of the biopharmaceutical industry
|
| 260 |
|
|
|a New York
|b Oxford University Press
|c 2012, c2012
|
| 300 |
|
|
|a 1 online resource (xix, 597 p.)
|b ill
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 653 |
|
|
|a Pharmaceutical industry
|
| 653 |
|
|
|a Biopharmaceutics / Economic aspects
|
| 700 |
1 |
|
|a Nicholson, Sean
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b OHO
|a Oxford Handbook Online
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1093/oxfordhb/9780199742998.001.0001?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 338.476157
|
| 520 |
|
|
|a This examination of the economics of the biopharmaceutical industry has 18 chapters by health economists. Part 1 examines the economics of biopharmaceutical innovation. Part 2 examines the market for biopharmaceuticals with chapters on prices and reimbursement in industrialised and developing countries
|